Our Vision: MicroVention’s goal is to be the leading global neurovascular company. We will accomplish this goal by producing the most reliable, easiest to use and most technologically advanced products supported by proven clinical data.

Internet Explorer users: This website is best viewed with Compatibility Mode disabled. You may need to change your setting to view this site.

 


  • MICROVENTION & SEQUENT MEDICAL
    Terumo Corporation Acquires Sequent Medical: MicroVention Gains Developer of New Aneurysm Embolization Device

  • MICROVENTION CELEBRATES GRAND OPENING
    Relocates to New WW Innovation Center at Summit Office Campus in Aliso Viejo
  • MV Island Booth
    LINNC ASIA 2017 - Singapore
    November 17-18, 2017. Come visit us during the meeting.